• Users Online: 252
  • Home
  • Print this page
  • Email this page
Home About us Editorial board Ahead of print Current issue Search Archives Submit article Instructions Contacts Reader Login
Export selected to
Reference Manager
Medlars Format
RefWorks Format
BibTex Format
  Citation statistics : Table of Contents
   2009| July-August  | Volume 1 | Issue 1  
    Online since July 18, 2017

  Archives   Next Issue   Most popular articles   Most cited articles
Hide all abstracts  Show selected abstracts  Export selected to
  Cited Viewed PDF
Ibnosina Journal of Medicine and Biomedical Sciences
Omar Bagasra
July-August 2009, 1(1):1-1
Full text not available  [PDF] [CITATIONS]
  1 197 58
The practices and outcomes of diabetic patients during ramadan fast: A survey in a specialist clinic
SA Beshyah, MM Benbarka, AB Khalil
July-August 2009, 1(1):16-19
Assessment was made by semi-structured interview of the practices and outcomes of diabetic patients during Ramadan fasting. Data collected included demographic data, diabetes details, medications and HbA1c levels. Patients were questioned about fasting, changes in medications, and outcomes in terms of hypoglycemia, hyperglycemia, and emergency hospital visits. Three hundred and thirteen nonpregnant adult patients were surveyed during the six weeks after Ramadan. Median age was 53 (range 11 to 87) years. One hundred and sixty nine patients (54%) were women and the majority were UAE nationals. The median duration of known diabetes was 10 years (range 1-35). The majority had type 2 diabetes (n=276 or 88%) and 37 patients had type 1 diabetes. The majority of patients with type 1 diabetes (n=30/38) received intensive insulin regimens. Patients with type 2 diabetes were treated with intensive insulin regimen (n=28 or 10%), twice daily insulin regimen (n=40 or 14%) and basal insulin (n=52 or 19%) with or without oral agents. Oral anti-diabetic therapy was used in 156 (57%). The mean HbA1c was 8.7% with a median of 8.1(5.5-17.6%) measured at a median of two months (range 1-12) before Ramadan. Fifteen patients did not fast (4.8%) of whom four did not fast for other medical reasons, and of the total five had type 1 diabetes. Fasting was observed by 258 patients (82%), for > 20 days by 31 patients (10%), between 10-20 days by 7 patients (2.2%) and for <10 days by two patients (0.6%). The total daily dose was unchanged in 209/298 (70%), was reduced by 83 (28%) and stopped completely by 5 patients (2%). Patients took their medication as three doses (6.4%), two doses (81%) or a single dose (12%). No hypoglycemia was reported in 253 patients. However, in 26, 6, and 11 patients hypoglycemia lead to breaking the fast in 1-3, 4-6 and >7 days respectively. Unusually high hyperglycemia was reported by 33 patients with values around 200-400 mg/dL. Admission to hospital was needed by three patients. In conclusion, most patients with diabetes do fast during Ramadan with changes in their medications' total dose and frequency. Hypoglycemia is the most common complication in insulin-dependent diabetic patients.
[ABSTRACT]   Full text not available  [PDF] [CITATIONS]
  1 393 57
Abstracts of the Seventh Libyan Diabetes and Endocrinology Conference April 7-9, 2009 Tripoli, Libya
Amna A Salhin, Salem A Beshyah
July-August 2009, 1(1):25-43
Full text not available  [PDF]
  - 0 0
Emphysematous cystitis: An unusual disease of the bladder diagnosed on imaging
Sataa Sallami, Sami Ben Rhouma, Ali Horchani
July-August 2009, 1(1):20-24
Emphysematous cystitis (EC) is defined by the presence of gas in the urinary bladder wall. This rare disease entity is caused by gas fermenting bacterial and fungal pathogens. It complicates urinary tract infections especially in diabetic patients but other disabling general medical conditions may be present. Because the clinical symptoms are nonspecific, the diagnosis is often made incidentally on X-rays. Early diagnosis and treatment improve the outcome. We report a case of 83-year-old diabetic female who presented with fever, dysuria and gross hematuria. Ultrasonography and computed tomography revealed gas accumulation in the wall and lumen of the bladder leading to the diagnosis of emphysematous cystitis. She was treated with antibiotics, insulin, rehydratation and a Foley catheter placement. Diabetic patients with urinary tract infections who are severely ill should have radiological investigations to rule out the prsence of emphysematous complications.
[ABSTRACT]   Full text not available  [PDF]
  - 355 46
Even a single, remotely positive post-transplant alloantibody test correlates with increased chronic allograft nephropathy and graft loss after kidney transplantation
Ronald P Pelletier, Gregg Hadley, Patrick Adams, Mitchell L Henry, Zhangsheng Yu, Ronald M Ferguson
July-August 2009, 1(1):7-15
Background: Chronic renal allograft loss is considered as immunologically mediated when donor-specific alloantibodies are detected. However, remotely detected alloantibodies with lack of detection more proximate to graft loss occurrence may obscure the humoral association with graft damage. Methods: We retrospectively reviewed 609 patients multiply tested post-transplant for detectable alloantibodies and correlated their results with clinical outcomes. Results: Most patients had no detectable post-transplant alloantibodies (Group 1, n = 393), some converted from nondetectable to detectable alloantibodies (Group 2, n = 97), some always had detectable post-transplant alloantibodies (Group 3, n = 69), and some demonstrated alloantibodies that subsequently became undetectable (Group 4, n = 50). The incidence of death-censored graft survival for Group 4 patients was similar to Group 2 and 3 patients, and greater than Group 1 patients. Further, interstitial fibrosis/tubularatrophy (IF/TA) free survival was significantly worse (p=0.018) for Group 4 versus Group 1 recipients. Also, Group 4 versus Group 1 IF/TA-free survival was worse when recipients were regrouped based solely on anti-HLA class II (p=0.006), but not anti-HLA class I (p=ns) antibodies. Conclusions: Detectable anti-HLA antibodies, even remotely, post-transplant identifies recipients at greater risk for IF/TA associated graft loss when compared to patients without detectable alloantibodies.
[ABSTRACT]   Full text not available  [PDF]
  - 372 50
The management of rhinosinusitis with intensive combined medical treatment: Auditing of a practice
Mohamed H Benamer, Mohammed S Hammed
July-August 2009, 1(1):2-6
The medical treatment of chronic and recurrent rhinosinusitis remains up to the primary care doctors if not the patients themselves. It is always a debate among physicians what should we order. In this study we audit our management as a secondary referral centre. We prospectively followed twelve patients after receiving intensive medical treatment with antibiotics, intranasal decongestants and intranasal steroids. It was found that with intensive combined medical treatment 84% of the patients improved, and only on 8% required surgical intervention. Hospital visits were reduced from 2.7 visits per patient to one. The mean time for decision taken reduced from 141.1days to 55.5 days and time waited for operation to take time reduced from 249.4 to 17 days. This treatment reduces the need to treat surgically, reduces hospital visits and save time.
[ABSTRACT]   Full text not available  [PDF]
  - 374 58